Multiple sclerosis: overview of disease-modifying agents
about
Mindfulness-based stress reduction for people with multiple sclerosis - a feasibility randomised controlled trialOriental Medicine Samhwangsasim-tang Alleviates Experimental Autoimmune Encephalomyelitis by Suppressing Th1 Cell Responses and Upregulating Treg Cell Responses.An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.Co-ultramicronized Palmitoylethanolamide/Luteolin Promotes the Maturation of Oligodendrocyte Precursor CellsCo-Ultramicronized Palmitoylethanolamide/Luteolin Facilitates the Development of Differentiating and Undifferentiated Rat Oligodendrocyte Progenitor Cells.Baseline predictors of DMT reinitiation among patients with multiple sclerosis following an MI-CBT intervention.Oligodendrocyte Progenitor Cell Cultures: A Model to Screen Neurotrophic Compounds for Myelin Repair.Effects of Torso-Weighting on Standing Balance and Falls During the Sensory Organization Test in People with Multiple Sclerosis.
P2860
Q30851153-457582FE-5163-42EF-8EF7-949CC60F6BC5Q33571722-3550F9F7-21C4-49B4-BE3C-55271BA293EAQ36132119-854C3188-75E9-4ACE-9D9C-0189A5DB0A6FQ36290946-CAABFABB-BB53-4EFA-9241-956086C04752Q47932285-C93AC862-F81A-4181-8496-1D6DC6DDF190Q47976066-3EA8933A-075D-4FFE-9BA5-00544C364B16Q49985770-6D5330C6-21E7-42B6-A1DD-1BD71EAE2147Q55312521-979385B9-35B6-43C1-959D-81944D11AADF
P2860
Multiple sclerosis: overview of disease-modifying agents
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Multiple sclerosis: overview of disease-modifying agents
@ast
Multiple sclerosis: overview of disease-modifying agents
@en
Multiple sclerosis: overview of disease-modifying agents
@nl
type
label
Multiple sclerosis: overview of disease-modifying agents
@ast
Multiple sclerosis: overview of disease-modifying agents
@en
Multiple sclerosis: overview of disease-modifying agents
@nl
prefLabel
Multiple sclerosis: overview of disease-modifying agents
@ast
Multiple sclerosis: overview of disease-modifying agents
@en
Multiple sclerosis: overview of disease-modifying agents
@nl
P2860
P356
P1476
Multiple sclerosis: overview of disease-modifying agents
@en
P2093
Alessandro Finkelsztejn
P2860
P356
10.4137/PMC.S13213
P577
2014-10-05T00:00:00Z